Indivior PLC Ordinary Shares (INDV) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $33.71
• Market Cap: $4.20B
• P/E Ratio: 34.32
• EPS: $0.98
• 52-Week High: $38.00
• 52-Week Low: $8.34

Market Sentiment

Indivior PLC Ordinary Shares currently has a Bullish sentiment score of 0.25.

About Indivior PLC Ordinary Shares

Indivior PLC is a leading global biopharmaceutical company headquartered in North Chesterfield, Virginia, specializing in the development and commercialization of innovative treatments for opioid dependence and related disorders, particularly through its proprietary buprenorphine-based therapies. The company is dedicated to improving patient outcomes by addressing the complex challenges of opioid use disorder and is committed to advancing research and development in this critical area of publ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Indivior PLC Ordinary Shares and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does INDV pay dividends?

Indivior PLC Ordinary Shares (INDV) does not currently pay a regular dividend.

What is INDV's P/E ratio?

Indivior PLC Ordinary Shares has a price-to-earnings (P/E) ratio of 34.32.

What is INDV's market cap?

Indivior PLC Ordinary Shares (INDV) has a market capitalization of $4.20B with a current stock price of $33.71.